ReviewCurrent opinion in oncology2026
Deep learning assisting the surgical management of gynecologic cancers.
Review in Current opinion in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis review examines the current role of deep learning in the surgical management of gynecologic cancers. It aims to evaluate applications across surgical training, intraoperative guidance, and outcome prediction, while identifying limitations that hinder translation into routine clinical practice. RECENT
findingsDeep learning-based systems show promising performance in enhancing surgical skills through objective assessment and simulation platforms. Intraoperatively, deep learning models can recognize anatomical structures, surgical phases, and tumor tissue, with high diagnostic accuracy in selected settings. Emerging techniques such as surgical optomics and hyperspectral imaging may further improve tumor detection. Additionally, predictive models integrating clinical, imaging, and intraoperative data demonstrate potential in estimating complications, resource utilization, and survival outcomes. However, most studies are retrospective, based on limited datasets, and lack external validation, with minimal evidence of real-world clinical impact. SUMMARY: Artificial intelligence, particularly deep learning algorithms, represents a rapidly evolving tool in gynecologic oncologic surgery, with potential to standardize and personalize care. Nevertheless, significant gaps remain between experimental performance and clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.